New stock news | China Medical Technology submits application to Hong Kong Stock Exchange
According to the prospectus, the National Medical Technology is the leader in China's third-party SPD solution market.
According to the disclosure on Hong Kong Stock Exchange on January 21, Anhui Zhongxi Guoyi Medical Technology Co., Ltd. (referred to as "Guoyi Technology") has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with Haitong International Capital Limited as its exclusive sponsor. According to the prospectus, Guoyi Technology is the leader in China's third-party SPD solution market. According to Frost & Sullivan report, based on the revenue in 2024, Guoyi Technology is the largest third-party SPD solution provider in China, with a market share of 29.2%. According to the same report, the company is also the first third-party SPD solution provider in China.
Related Articles

YUEXIUTRANSPORT (01052) obtains a revolving loan financing of 450 million RMB.

ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer
YUEXIUTRANSPORT (01052) obtains a revolving loan financing of 450 million RMB.

ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


